Kim TW - Search Results

1

Enhancement of DC vaccine potency by activating the PI3K/AKT pathway with a small interfering RNA targeting PTEN.

Kim JH, Kang TH, Noh KH, Kim SH, Lee YH, Kim KW, Bae HC, Ahn YH, Choi EY, Kim JS, Lee KM, Kim TW. Kim JH, et al. Among authors: kim tw, kim sh, kim js, kim kw. Immunol Lett. 2010 Nov 30;134(1):47-54. doi: 10.1016/j.imlet.2010.08.008. Epub 2010 Aug 19. Immunol Lett. 2010. PMID: 20727912

2

Enhancement of dendritic cell-based vaccine potency by targeting antigen to endosomal/lysosomal compartments.

Kang TH, Lee JH, Bae HC, Noh KH, Kim JH, Song CK, Shin BC, Hung CF, Wu TC, Park JS, Kim TW. Kang TH, et al. Among authors: kim tw, kim jh. Immunol Lett. 2006 Aug 15;106(2):126-34. doi: 10.1016/j.imlet.2006.05.004. Epub 2006 May 22. Immunol Lett. 2006. PMID: 16844231

3

Enhancing dendritic cell vaccine potency by combining a BAK/BAX siRNA-mediated antiapoptotic strategy to prolong dendritic cell life with an intracellular strategy to target antigen to lysosomal compartments.

Kang TH, Lee JH, Noh KH, Han HD, Shin BC, Choi EY, Peng S, Hung CF, Wu TC, Kim TW. Kang TH, et al. Among authors: kim tw. Int J Cancer. 2007 Apr 15;120(8):1696-703. doi: 10.1002/ijc.22377. Int J Cancer. 2007. PMID: 17230516

4

Activation of Akt as a mechanism for tumor immune evasion.

Noh KH, Kang TH, Kim JH, Pai SI, Lin KY, Hung CF, Wu TC, Kim TW. Noh KH, et al. Among authors: kim tw, kim jh. Mol Ther. 2009 Mar;17(3):439-47. doi: 10.1038/mt.2008.255. Epub 2008 Dec 23. Mol Ther. 2009. PMID: 19107122 Free PMC article.

5

Enhancement of dendritic cell-based vaccine potency by anti-apoptotic siRNAs targeting key pro-apoptotic proteins in cytotoxic CD8(+) T cell-mediated cell death.

Kim JH, Kang TH, Noh KH, Bae HC, Kim SH, Yoo YD, Seong SY, Kim TW. Kim JH, et al. Among authors: kim tw, kim sh. Immunol Lett. 2009 Jan 29;122(1):58-67. doi: 10.1016/j.imlet.2008.12.006. Epub 2009 Jan 9. Immunol Lett. 2009. PMID: 19135479

6

Modification of dendritic cells with interferon-gamma-inducible protein-10 gene to enhance vaccine potency.

Kang TH, Bae HC, Kim SH, Seo SH, Son SW, Choi EY, Seong SY, Kim TW. Kang TH, et al. Among authors: kim tw, kim sh. J Gene Med. 2009 Oct;11(10):889-98. doi: 10.1002/jgm.1371. J Gene Med. 2009. PMID: 19618483

7

Pem renders tumor cells resistant to apoptotic cell death induced by a CD8+ T cell-mediated immune response or anticancer drug treatment.

Kim SH, Kim KW, Kim JH, Noh KH, Bae HC, Lee TH, Kim TW. Kim SH, et al. Among authors: kim tw, kim kw, kim jh. Cancer Lett. 2010 Jul 28;293(2):181-8. doi: 10.1016/j.canlet.2010.01.008. Epub 2010 Feb 6. Cancer Lett. 2010. PMID: 20137854

8

Enhancement of DNA vaccine potency by antigen linkage to IFN-γ-inducible protein-10.

Kang TH, Kim KW, Bae HC, Seong SY, Kim TW. Kang TH, et al. Among authors: kim tw, kim kw. Int J Cancer. 2011 Feb 1;128(3):702-14. doi: 10.1002/ijc.25391. Int J Cancer. 2011. PMID: 20473881

9

Cancer vaccination drives Nanog-dependent evolution of tumor cells toward an immune-resistant and stem-like phenotype.

Noh KH, Lee YH, Jeon JH, Kang TH, Mao CP, Wu TC, Kim TW. Noh KH, et al. Among authors: kim tw. Cancer Res. 2012 Apr 1;72(7):1717-27. doi: 10.1158/0008-5472.CAN-11-3758. Epub 2012 Feb 14. Cancer Res. 2012. PMID: 22337995 Free PMC article.

10

Chemotherapy enhances CD8(+) T cell-mediated antitumor immunity induced by vaccination with vaccinia virus.

Song CK, Han HD, Noh KH, Kang TH, Park YS, Kim JH, Park ES, Shin BC, Kim TW. Song CK, et al. Among authors: kim tw, kim jh. Mol Ther. 2007 Aug;15(8):1558-63. doi: 10.1038/sj.mt.6300221. Epub 2007 Jun 5. Mol Ther. 2007. PMID: 17551502 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,604 results

Search Page

Filters